
Géraldine Farjot Appointed as Head of Innovation at Paris Brain Institute, Driving New Momentum for iPEPS
Paris Brain Institute has appointed Géraldine Farjot as its new Head of Innovation, entrusting her with a pivotal role in fostering breakthroughs in neuroscience and healthcare. This strategic division includes iPEPS, the Institute’s incubator, which is central to transforming scientific discoveries into tangible solutions for patients.
Since its inception, Paris Brain Institute has established itself as a major player in medical innovation, creating mechanisms to identify and support high-potential projects. Through initiatives like iPEPS, the Institute helps mitigate the risks of early-stage development, accelerating the journey of innovations toward clinical trials and, in some cases, commercial deployment.
iPEPS: A Driver of Innovation in Health Startups
iPEPS, the incubator of Paris Brain Institute, serves as a catalyst for entrepreneurship in healthcare. With cutting-edge infrastructure and a collaborative ecosystem, it hosts startups that aim to translate scientific research into innovative products and services. This incubation model fosters solutions for complex neurological and psychiatric disorders while forging robust ties with industrial and academic partners.
Géraldine Farjot brings extensive expertise to this mission, with a career spanning major pharmaceutical companies such as Sanofi and Air Liquide Healthcare, as well as innovative biotech ventures like Samsara Therapeutics. Her vision is to enhance iPEPS’s impact on the health innovation landscape.
“iPEPS embodies health innovation through tailored support for startups. By empowering visionary entrepreneurs, we provide them with the scientific, legal, and entrepreneurial expertise necessary to develop solutions that address the needs of patients and healthcare providers.”
Géraldine Farjot
An Incubator at the Heart of the Healthcare Ecosystem
With around 30 startups incubated each year, iPEPS stands out for its integrated approach, combining technological support, strategic mentoring, and networking opportunities. Its unique location within the Pitié-Salpêtrière Hospital offers startups a significant advantage by enabling real-world validation of their innovations.
iPEPS also facilitates collaborations between researchers, entrepreneurs, and healthcare professionals. These synergies accelerate the implementation of health projects while maximizing their impact, whether they involve medical devices, digital applications, or innovative therapies.
A Bold Vision for the Future
Under Géraldine Farjot’s leadership, iPEPS aims to expand its capacity to attract and support cutting-edge startups. Initiatives such as the Genov innovation unit, dedicated to gene therapy, and projects developed within the Care Lab benefit from the incubator’s multidisciplinary expertise, helping transform prototypes into concrete solutions.
“iPEPS is more than an incubator; it’s a true innovation lab for health. By multiplying partnerships and strengthening collaborations with academic and industrial ecosystems, we can support entrepreneurs and researchers in creating impactful tools that align with market and patient needs.”
Géraldine Farjot
With this renewed momentum, iPEPS and the broader Innovation Division aim to position Paris Brain Institute as a leader in health innovation both in France and internationally. By supporting the most promising projects, the incubator plays a central role in fulfilling the Institute’s mission: to improve patients’ lives through accessible and tangible scientific advancements.